Advertisement
Banner Health Children

Sanofi drug Dupixent wins FDA approval to treat asthma

Oct 20, 2018 , Reuters
France's Sanofi SA said on Friday eczema drug Dupixent was approved by the U.S. Food and Drug Administration as an additional maintenance therapy in patients with two types of asthma.


Read the full story...


Trending healthcare news keywords at this moment

kids fda cancer drug common patients cdc outbreak disease test hospital care digital marketing media adds years life study medical tip safety americans measles state risk public healthcare report launches salmonella states people finds linked age buy cases higher therapy diabetes opioid heart york food raises doctors